Franklin Resources’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303M | Buy |
|
|||||
|
2025
Q1 | $256M | Buy |
|
|||||
|
2024
Q4 | $187M | Sell |
|
|||||
|
2024
Q3 | $188M | Sell |
|
|||||
|
2024
Q2 | $284M | Buy |
|
|||||
|
2024
Q1 | $300M | Buy |
|
|||||
|
2023
Q4 | $134M | Sell |
|
|||||
|
2023
Q3 | $114M | Sell |
|
|||||
|
2023
Q2 | $108M | Sell |
|
|||||
|
2023
Q1 | $144M | Sell |
|
|||||
|
2022
Q4 | $168M | Buy |
|
|||||
|
2022
Q3 | $119M | Buy |
|
|||||
|
2022
Q2 | $89.1M | Buy |
|
|||||
|
2022
Q1 | $108M | Buy |
|
|||||
|
2021
Q4 | $124M | Buy |
|
|||||
|
2021
Q3 | $132M | Buy |
|
|||||
|
2021
Q2 | $104M | Buy |
|
|||||
|
2021
Q1 | $94.4M | Buy |
|
|||||
|
2020
Q4 | $122M | Buy |
|
|||||
|
2020
Q3 | $110M | Buy |
|
|||||
|
2020
Q2 | $99.5M | Sell |
|
|||||
|
2020
Q1 | $78.8M | Sell |
|
|||||
|
2019
Q4 | $114M | Sell |
|
|||||
|
2019
Q3 | $84.6M | Buy |
|
|||||
|
2019
Q2 | $101M | Sell |
|
|||||
|
2019
Q1 | $103M | Buy |
|
|||||
|
2018
Q4 | $38.9M | Buy |
|
|||||
|
2018
Q3 | $41.9M | Buy |
|
|||||
|
2018
Q2 | $36.5M | Buy |
|
|||||
|
2018
Q1 | $32.8M | Buy |
|